The effect of dobutamine vs milrinone in sepsis: A big data, real‐world study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect of dobutamine vs milrinone in sepsis: A big data, real‐world study

Published:2021-09-07 Issue:11 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Zhu Youfeng¹^ORCID,Yin Haiyan²,Zhang Rui¹,Ye Xiaoling¹,Wei Jianrui³

Affiliation:

1. Department of Intensive Care Unit Guangzhou Red Cross Hospital Jinan University Guangzhou China

2. Department of Critical Care Medicine The First Affiliated Hospital of Jinan University Guangzhou China

3. Guangzhou Women and Children's Medical Center Guangzhou China

Funder

Guangzhou Science, Technology and Innovation Commission

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14689

Reference32 articles.

1. Actual incidence of global left ventricular hypokinesia in adult septic shock

2. Vasopressors During Sepsis

3. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

4. Acute haemodynamic effects of dobutamine in experimental sepsis-induced myocardial depression

5. Catecholamine treatment for shock—equally good or bad?

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase 3 inhibitors do not influence lactate kinetics and clinical outcomes in patients with septic shock: A multicentre cohort study;Journal of Critical Care;2024-10

2. Chinese experts’ consensus on the application of intensive care big data;Frontiers in Medicine;2024-01-08

3. Benefits and Risks of Medications Used in the Management of Hypotension: A Review;Cureus;2024-01-03

4. Boosting the Beat: A Critical Showdown of Levosimendan and Milrinone in Surgical and Non-Surgical Scenarios: A Narrative Review;Journal of Cardiovascular Pharmacology and Therapeutics;2024-01

5. The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock;Expert Review of Clinical Pharmacology;2022-08-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3